New buyers from the conference are waiting for the audit results before buying in. I'd have thought that would be obvious.
They've now heard about RXMD, and are holding off until the audit is complete. That's perfectly reasonable. These aren't hobbyists with an extra $500 to play with.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.